CAS 1181226-02-7

4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid

CAS : 1181226-02-7

Formule : C₁₄H₁₁Cl₂NO₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 328.1474

Ref: IN-DA008TPQ

ZL006

CAS : 1181226-02-7

ZL006

Degré de pureté : ≥98%

Masse moléculaire : 328.15g/mol

Ref: 54-BUP10170

ZL006

CAS : 1181226-02-7

ZL006 is an effective inhibitor of nNOS/PSD-95 interaction. ZL006 also inhibits NMDA receptor-mediated NO synthesis.

Formule : C₁₄H₁₁Cl₂NO₄

Degré de pureté : 98.29%

Couleur et forme : Solid

Masse moléculaire : 328.15

Ref: TM-T17293

ZL006

CAS : 1181226-02-7

ZL006 is a potential drug target that has been shown to inhibit the activity of GABA transaminase, an enzyme that breaks down the neurotransmitter γ-aminobutyric acid. It also inhibits neuronal death caused by ischemia reperfusion injury in rats and may have therapeutic effects on Parkinson's disease. ZL006 has a hydroxyl group at the para position, which is important for its pharmacological properties. It also has inhibitory properties against locomotor activity in rats and rotarod test performance in mice. ZL006 has been shown to be well absorbed orally and distributed throughout the body after intravenous administration, with a half-life of approximately 45 minutes.

Formule : C₁₄H₁₁Cl₂NO₄

Degré de pureté : Min. 95%

Masse moléculaire : 328.15 g/mol

Ref: 3D-GXB22602